About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Col1a1-cre)1Ack
transgene insertion 1, Andrew C Karaplis
MGI:3603124
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Pthlhtm1Ack/Pthlhtm1Ack
Tg(Col1a1-cre)1Ack/0
involves: 129S1/Sv * 129X1/SvJ * FVB/N MGI:3617818
cn2
Gt(ROSA)26Sortm4(Wnt7b)Flng/Gt(ROSA)26Sor+
Tg(Col1a1-cre)1Ack/0
involves: FVB/N MGI:5613584
cn3
Gt(ROSA)26Sortm5(Wnt5a)Flng/Gt(ROSA)26Sortm5(Wnt5a)Flng
Tg(Col1a1-cre)1Ack/0
involves: FVB/N MGI:5613587


Genotype
MGI:3617818
cn1
Allelic
Composition
Pthlhtm1Ack/Pthlhtm1Ack
Tg(Col1a1-cre)1Ack/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pthlhtm1Ack mutation (0 available); any Pthlh mutation (19 available)
Tg(Col1a1-cre)1Ack mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• the number and surface of osteoclasts is reduced by 43% and 52%, respectively
• long bones appear less radiopaque and bone mineral density is decreased
• osteoblast number and surface are decreased by 55% and 60%, respectively and osteoid volume is decreased by 75%
• the percentage of apoptotic osteoblasts/osteocytes is increased more than 8-fold compared to controls
• the bone marrow space is increased with only scattered thin spicules of trabecular bone trabecular number and thickness are decreased and trabecular separation is increased in the distal femur and proximal tibia
• however, there is no increase in bone marrow adiposity unlike Pthlh null homozygotes
• the mineral apposition rate is decreased by 45% and 60% in the tibial cortex and trabeculae, respectively

hematopoietic system
• the number and surface of osteoclasts is reduced by 43% and 52%, respectively

immune system
• the number and surface of osteoclasts is reduced by 43% and 52%, respectively




Genotype
MGI:5613584
cn2
Allelic
Composition
Gt(ROSA)26Sortm4(Wnt7b)Flng/Gt(ROSA)26Sor+
Tg(Col1a1-cre)1Ack/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm4(Wnt7b)Flng mutation (0 available); any Gt(ROSA)26Sor mutation (942 available)
Tg(Col1a1-cre)1Ack mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• proximal tibial trabecular bone volume/total volume is increased 13.7 fold and 5.1 fold at 2 months and 6 months of age, respectively
• by 9 months of age bone mass of the proximal tibial trabecular area is 30% less than controls
• osteoclast number per bone surface and percentage of bone resorption surface are reduced at 2 months of age
• absence of a marrow space in the long bones due to complete ossification
• profoundly dense bones in both males and females throughout the body at 2 months of age
• increased density persists at 6 months of age but is partially resolved at 9 months of age
• by 9 months of age bone mass of the proximal tibial trabecular area is 30% less than controls
• however, bone mass remains increased in the distal tibia and femur at 9 months of age
• proximal tibial trabecular bone volume/total volume is increased 13.7 fold and 5.1 fold at 2 months and 6 months of age, respectively
• excessive osteoblasts in the presumptive marrow cavity at E18.5
• increased osteoblast number normalized to bone surface at 2 months of age
• however, the density of osteocytes is similar to controls
• excessive bone occupies both primary and secondary ossification centers but the growth plate remains largely normal
• increased bone mass is seen at E18.5 and at 2 and 6 months of age
• mineral apposition rate, the percentage of mineralizing surface, and bone formation rate are all increased in the humerus
• increase in the serum levels of C-terminal telopeptide of type I collagen (a degradation product of type I collagen released upon bone resorption) at 1 and 9 months of age but not at 2 months of age

homeostasis/metabolism
• increased at 1 and 2 months of age
• increase in the serum levels of C-terminal telopeptide of type I collagen (a degradation product of type I collagen released upon bone resorption) at 1 and 9 months of age but not at 2 months of age

hematopoietic system
• consistent with extramedullary hematopoiesis
• osteoclast number per bone surface and percentage of bone resorption surface are reduced at 2 months of age

immune system
• consistent with extramedullary hematopoiesis
• osteoclast number per bone surface and percentage of bone resorption surface are reduced at 2 months of age

limbs/digits/tail
• proximal tibial trabecular bone volume/total volume is increased 13.7 fold and 5.1 fold at 2 months and 6 months of age, respectively
• by 9 months of age bone mass of the proximal tibial trabecular area is 30% less than controls

growth/size/body
• consistent with extramedullary hematopoiesis




Genotype
MGI:5613587
cn3
Allelic
Composition
Gt(ROSA)26Sortm5(Wnt5a)Flng/Gt(ROSA)26Sortm5(Wnt5a)Flng
Tg(Col1a1-cre)1Ack/0
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm5(Wnt5a)Flng mutation (0 available); any Gt(ROSA)26Sor mutation (942 available)
Tg(Col1a1-cre)1Ack mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
N
• do not display any obvious bone phenotype at 2 months of age





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory